Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients: A Prospective Multicenter Registry (OPERA)

NCT01325935 is registered in ClinicalTrials.gov with Associations for Establishment of Evidence in Interventions as lead sponsor.

NCT NCT01325935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01325935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients: A Prospective Multicenter Registry (OPERA)
Lead sponsor
Associations for Establishment of Evidence in Interventions
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2011
Completion date
December 31, 2013
Enrollment
1,187 (actual)
Sites
112

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease